Ovintiv Announces Increasing Shareholder Returns with New Capital Allocation Framework
Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced a new capital allocation framework, which supports the Company’s goal of…
Global
Warby Parker to sell more than 77 million shares, trading to start in late September
Warby Parker Inc. has amended its prospectus to sell more than 77 million shares worth nearly $191 million in its upcoming direct…
Portage Fintech Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 10, 2021
Portage Fintech Acquisition Corporation (Nasdaq: PFTAU) (the “Company”) today announced that, commencing September 10, 2021,…
Stock Analysis
Portage Fintech Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 10, 2021
NEW YORK, Sept. 9, 2021 /PRNewswire/ – Portage Fintech Acquisition Corporation (Nasdaq: PFTAU) (the “Company”) today announced…
GTA 5 next-gen release date confirmed for March 2022
Trevor, Micheal, and Franklin make their triumphant return
Is Sphere 3D A Buy Ahead Of Merger With Gryphon Digital Mining?
While we believe Gryphon Digital Mining benefits from a positive long-term outlook, shares of ANY appear expensive following…
Sumo Logic stock falls 5% after quarterly results
Shares of Sumo Logic Inc. fell more than 5% in the extended session Thursday despite a quarterly beat for the software company….
Academy Sports and Outdoors, Inc. (ASO) CEO Ken Hicks on Q2 2021 Results – Earnings Call Transcript
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q2 2021 Earnings Conference Call September 9, 2021 11:00 AM ETCompany ParticipantsMatt…
Regulus Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative…
Regulus Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
SAN DIEGO, Sept. 9, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the…